Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    March 2021
  1. AKBAR U, McQueen RB, Bemski J, Carter J, et al
    Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review.
    J Neurol Neurosurg Psychiatry. 2021 Mar 31. pii: jnnp-2020-323939.
    PubMed     Abstract available


    February 2021
  2. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    PubMed     Abstract available


    January 2021
  3. LIN F, Wu D, Yu J, Weng H, et al
    Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2021 Jan 18. pii: jnnp-2020-323656.
    PubMed     Abstract available


  4. LYU Z, Zheng S, Zhang X, Mai Y, et al
    Olfactory impairment as an early marker of Parkinson's disease in REM sleep behaviour disorder: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2021 Jan 12. pii: jnnp-2020-325361.
    PubMed     Abstract available


    December 2020
  5. KAZMI H, Walker Z, Booij J, Khan F, et al
    Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson's disease: a cross-sectional study.
    J Neurol Neurosurg Psychiatry. 2020 Dec 2. pii: jnnp-2020-324266.
    PubMed     Abstract available


  6. PHILLIPS O, D'Abreu A, Friedman JH, Akbar U, et al
    Recognising hemihypomimia as a mimic of 'facial weakness'.
    J Neurol Neurosurg Psychiatry. 2020;91:1357-1358.
    PubMed    


    October 2020
  7. BAUMEISTER S, Meisinger C, Leitzmann M, Teumer A, et al
    Physical activity and Parkinson's disease: a two-sample Mendelian randomisation study.
    J Neurol Neurosurg Psychiatry. 2020 Oct 22. pii: jnnp-2020-324515.
    PubMed    


  8. JACOBS BM, Belete D, Bestwick J, Blauwendraat C, et al
    Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank.
    J Neurol Neurosurg Psychiatry. 2020;91:1046-1054.
    PubMed     Abstract available


  9. CLARIMON J
    Genetic-environmental factors finally assessed together in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020;91:1030.
    PubMed    


    September 2020
  10. MACEROLLO A, Holz C, Cletheror D, Vega J, et al
    Non-invasive intervention for motor signs of Parkinson's disease: the effect of vibratory stimuli.
    J Neurol Neurosurg Psychiatry. 2020 Sep 11. pii: jnnp-2020-323427.
    PubMed    


    July 2020
  11. RICHARDSON RM, Bankiewicz KS, Christine CW, Van Laar AD, et al
    Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Jul 30. pii: jnnp-2020-322904.
    PubMed     Abstract available


  12. KERN DS, Uy D, Rhoades R, Ojemann S, et al
    Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Jul 10. pii: jnnp-2019-322688.
    PubMed     Abstract available


    June 2020
  13. JANKOVIC J, Tan EK
    Parkinson's disease: etiopathogenesis and treatment.
    J Neurol Neurosurg Psychiatry. 2020 Jun 23. pii: jnnp-2019-322338.
    PubMed     Abstract available


    May 2020
  14. JENKINS PO, Roussakis AA, De Simoni S, Bourke N, et al
    Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 May 7. pii: jnnp-2019-321759.
    PubMed     Abstract available


  15. JOST ST, Sauerbier A, Visser-Vandewalle V, Ashkan K, et al
    A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    J Neurol Neurosurg Psychiatry. 2020 May 5. pii: jnnp-2019-322614.
    PubMed     Abstract available


  16. O'BRIEN J, Taylor JP, Ballard C, Barker RA, et al
    Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management.
    J Neurol Neurosurg Psychiatry. 2020;91:512-519.
    PubMed     Abstract available


    April 2020
  17. KELLY MJ, Baig F, Hu MT, Okai D, et al
    Spectrum of impulse control behaviours in Parkinson's disease: pathophysiology and management.
    J Neurol Neurosurg Psychiatry. 2020 Apr 30. pii: jnnp-2019-322453.
    PubMed     Abstract available


  18. STOKER TB, Camacho M, Winder-Rhodes S, Liu G, et al
    Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Apr 17. pii: jnnp-2020-322857.
    PubMed     Abstract available


  19. JIANG C, Hopfner F, Katsikoudi A, Hein R, et al
    Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
    J Neurol Neurosurg Psychiatry. 2020 Apr 9. pii: jnnp-2019-322588.
    PubMed     Abstract available


  20. STOKER TB, Camacho M, Winder-Rhodes S, Liu G, et al
    A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Apr 2. pii: jnnp-2019-322210.
    PubMed    


    March 2020
  21. O'SULLIVAN JD
    Too much of a good thing: hedonistic homoeostatic dysregulation and other behavioural consequences of excessive dopamine replacement therapy in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Mar 5. pii: jnnp-2019-322378.
    PubMed    


  22. SCHRAG A, Quinn N
    What contributes to quality of life in Parkinson's disease: a re-evaluation.
    J Neurol Neurosurg Psychiatry. 2020 Mar 5. pii: jnnp-2019-322379.
    PubMed    


    February 2020
  23. THOMAS GEC, Leyland LA, Schrag AE, Lees AJ, et al
    Brain iron deposition is linked with cognitive severity in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Feb 20. pii: jnnp-2019-322042.
    PubMed     Abstract available


    August 2019
  24. SMITH C, Malek N, Grosset K, Cullen B, et al
    Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    J Neurol Neurosurg Psychiatry. 2019 Aug 23. pii: jnnp-2019-321111.
    PubMed     Abstract available


  25. MILOSEVIC L, Kalia SK, Hodaie M, Lozano A, et al
    Subthalamic suppression defines therapeutic threshold of deep brain stimulation in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Aug 17. pii: jnnp-2019-321140.
    PubMed     Abstract available


  26. BARGIOTAS P, Debove I, Bargiotas I, Lachenmayer ML, et al
    Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.
    J Neurol Neurosurg Psychiatry. 2019 Aug 17. pii: jnnp-2019-320858.
    PubMed     Abstract available


    June 2019
  27. AVENALI M, Toffoli M, Mullin S, McNeil A, et al
    Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
    J Neurol Neurosurg Psychiatry. 2019 Jun 20. pii: jnnp-2019-320394.
    PubMed     Abstract available


  28. BARRETT MJ, Sperling SA, Blair JC, Freeman CS, et al
    Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2019 Jun 7. pii: jnnp-2019-320450.
    PubMed     Abstract available


    May 2019
  29. RICARDO Y, Pavon N, Alvarez L, Casabona E, et al
    Long-term effect of unilateral subthalamotomy for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 May 13. pii: jnnp-2019-320523.
    PubMed    


  30. PASQUINI J, Durcan R, Wiblin L, Gersel Stokholm M, et al
    Clinical implications of early caudate dysfunction in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 May 11. pii: jnnp-2018-320157.
    PubMed     Abstract available


    April 2019
  31. CHIVERS SEYMOUR K, Pickering R, Rochester L, Roberts HC, et al
    Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson's.
    J Neurol Neurosurg Psychiatry. 2019 Apr 3. pii: jnnp-2018-319448.
    PubMed     Abstract available


    March 2019
  32. JABBARI E, Woodside J, Guo T, Magdalinou NK, et al
    Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    J Neurol Neurosurg Psychiatry. 2019 Mar 13. pii: jnnp-2018-320151.
    PubMed     Abstract available


    February 2019
  33. BARBOSA PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, et al
    The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Feb 1. pii: jnnp-2018-319891.
    PubMed    


    January 2019
  34. LOW A, Foo H, Yong TT, Tan LCS, et al
    Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Jan 25. pii: jnnp-2018-319592.
    PubMed     Abstract available


  35. SHEPARD MD, Perepezko K, Broen MPG, Hinkle JT, et al
    Suicide in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Jan 19. pii: jnnp-2018-319815.
    PubMed     Abstract available


    December 2018
  36. LAWTON M, Ben-Shlomo Y, May MT, Baig F, et al
    Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.
    J Neurol Neurosurg Psychiatry. 2018;89:1279-1287.
    PubMed     Abstract available


    November 2018
  37. ORTEGA RA, Groves M, Mirelman A, Alcalay RN, et al
    Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2018 Nov 8. pii: jnnp-2018-319364.
    PubMed    


    October 2018
  38. MARTINEZ-CASTRILLO JC
    Impulse control disorders in Parkinson's disease: a hard-turning point.
    J Neurol Neurosurg Psychiatry. 2018 Oct 25. pii: jnnp-2018-319375.
    PubMed    


  39. LEE JY, Jeon B, Koh SB, Yoon WT, et al
    Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    J Neurol Neurosurg Psychiatry. 2018 Oct 25. pii: jnnp-2018-318942.
    PubMed     Abstract available


  40. WOJTALA J, Heber IA, Neuser P, Heller J, et al
    Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    J Neurol Neurosurg Psychiatry. 2018 Oct 8. pii: jnnp-2018-319008.
    PubMed     Abstract available


    September 2018
  41. LERCHE S, Wurster I, Roben B, Machetanz G, et al
    Parkinson's disease: evolution of cognitive impairment and CSF Abeta1-42 profiles in a prospective longitudinal study.
    J Neurol Neurosurg Psychiatry. 2018 Sep 25. pii: jnnp-2018-318956.
    PubMed     Abstract available


    August 2018
  42. SAWADA H, Oeda T, Kohsaka M, Umemura A, et al
    Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.
    J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318107.
    PubMed     Abstract available


  43. HUGHES KC, Gao X, Baker JM, Stephen C, et al
    Non-motor features of Parkinson's disease in a nested case-control study of US men.
    J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318275.
    PubMed     Abstract available


    July 2018
  44. VILAS D, Gelpi E, Aldecoa I, Grau O, et al
    Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318473.
    PubMed    


    June 2018
  45. AGARWAL S, Koch G, Hillis AE, Huynh W, et al
    Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.
    J Neurol Neurosurg Psychiatry. 2018 Jun 4. pii: jnnp-2017-317371.
    PubMed     Abstract available


    April 2018
  46. HUMPHRIES MD, Obeso JA, Dreyer JK
    Insights into Parkinson's disease from computational models of the basal ganglia.
    J Neurol Neurosurg Psychiatry. 2018 Apr 17. pii: jnnp-2017-315922.
    PubMed     Abstract available


    March 2018
  47. WISSEL BD, Dwivedi AK, Merola A, Chin D, et al
    Functional neurological disorders in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317378.
    PubMed     Abstract available


  48. HALLETT M
    Patients with Parkinson disease are prone to functional neurological disorders.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317684.
    PubMed    


  49. RADDER DLM, Nonnekes J, Bloem BR
    Intensive inpatient rehabilitation for persons with Parkinson's disease: last resort or pre-emptive strike?
    J Neurol Neurosurg Psychiatry. 2018 Mar 13. pii: jnnp-2017-317812.
    PubMed    


    February 2018
  50. ABBES M, Lhommee E, Thobois S, Klinger H, et al
    Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.
    J Neurol Neurosurg Psychiatry. 2018 Feb 7. pii: jnnp-2017-316373.
    PubMed     Abstract available


    January 2018
  51. BLOMSTEDT P, Stenmark Persson R, Hariz GM, Linder J, et al
    Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation.
    J Neurol Neurosurg Psychiatry. 2018 Jan 31. pii: jnnp-2017-317219.
    PubMed     Abstract available


  52. MALEK N, Weil RS, Bresner C, Lawton MA, et al
    Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study.
    J Neurol Neurosurg Psychiatry. 2018 Jan 29. pii: jnnp-2017-317348.
    PubMed     Abstract available


  53. BOT M, Schuurman PR, Odekerken VJJ, Verhagen R, et al
    Deep brain stimulation for Parkinson's disease: defining the optimal location within the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry. 2018 Jan 20. pii: jnnp-2017-316907.
    PubMed     Abstract available


  54. FERRAZZOLI D, Ortelli P, Zivi I, Cian V, et al
    Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316437.
    PubMed     Abstract available


    December 2017
  55. RODRIGUEZ-ROJAS R, Carballo-Barreda M, Alvarez L, Guridi J, et al
    Subthalamotomy for Parkinson's disease: clinical outcome and topography of lesions.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-316241.
    PubMed     Abstract available


    November 2017
  56. BARBOSA PM, Grippe T, Lees AJ, O'Sullivan S, et al
    Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.
    J Neurol Neurosurg Psychiatry. 2017 Nov 24. pii: jnnp-2017-317298.
    PubMed    


    October 2017
  57. RICCIARDI L, Lambert C, Micco R, Morgante F, et al
    Can we predict development of impulsive-compulsive behaviours in Parkinson's disease?
    J Neurol Neurosurg Psychiatry. 2017 Oct 27. pii: jnnp-2017-317007.
    PubMed     Abstract available


  58. FANTINI ML, Figorilli M, Arnulf I, Zibetti M, et al
    Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder.
    J Neurol Neurosurg Psychiatry. 2017 Oct 24. pii: jnnp-2017-316576.
    PubMed     Abstract available


  59. WARREN N, O'Gorman C, Lehn A, Siskind D, et al
    Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.
    J Neurol Neurosurg Psychiatry. 2017 Oct 10. pii: jnnp-2017-315985.
    PubMed     Abstract available


  60. SIMUNI T, Caspell-Garcia C, Coffey CS, Weintraub D, et al
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
    J Neurol Neurosurg Psychiatry. 2017 Oct 6. pii: jnnp-2017-316213.
    PubMed     Abstract available


    September 2017
  61. YE BS, Jeon S, Yoon S, Kang SW, et al
    Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 26. pii: jnnp-2017-316075.
    PubMed     Abstract available


  62. CHUNG SJ, Yoo HS, Moon H, Oh JS, et al
    Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    J Neurol Neurosurg Psychiatry. 2017 Sep 14. pii: jnnp-2017-315873.
    PubMed     Abstract available


  63. JOLING M, van den Heuvel OA, Berendse HW, Booij J, et al
    Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 12. pii: jnnp-2017-316193.
    PubMed     Abstract available


  64. THOMPSON JA, Tekriwal A, Felsen G, Ozturk M, et al
    Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry. 2017 Sep 2. pii: jnnp-2017-316115.
    PubMed     Abstract available


    August 2017
  65. SUZUKI K, Okuma Y, Uchiyama T, Miyamoto M, et al
    Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    J Neurol Neurosurg Psychiatry. 2017 Aug 28. pii: jnnp-2017-316136.
    PubMed     Abstract available


  66. ROSSI PJ, Shute JB, Opri E, Molina R, et al
    Impulsivity in Parkinson's disease is associated with altered subthalamic but not globus pallidus internus activity.
    J Neurol Neurosurg Psychiatry. 2017 Aug 19. pii: jnnp-2016-315325.
    PubMed     Abstract available


    July 2017
  67. CILIA R, Asselta R, Cereda E, Benfante R, et al
    Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jul 19. pii: jnnp-2017-316235.
    PubMed    


    June 2017
  68. VAN DER KOLK NM, de Vries NM, Penko AL, van der Vlugt M, et al
    A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315728.
    PubMed    


  69. AARSLAND D, Rajkumar AP, Hye A
    Novel evidence associates higher plasma alpha-synuclein levels and cognitive impairment in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315821.
    PubMed    


  70. NISHIO Y, Yokoi K, Uchiyama M, Mamiya Y, et al
    Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315741.
    PubMed     Abstract available


    May 2017
  71. AMARA AW, Chahine LM, Caspell-Garcia C, Long JD, et al
    Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 29. pii: jnnp-2016-315023.
    PubMed     Abstract available


  72. LIN CH, Yang SY, Horng HE, Yang CC, et al
    Plasma alpha-synuclein predicts cognitive decline in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 26. pii: jnnp-2016-314857.
    PubMed     Abstract available


    April 2017
  73. FFYTCHE DH, Pereira JB, Ballard C, Chaudhuri KR, et al
    Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    J Neurol Neurosurg Psychiatry. 2017;88:325-331.
    PubMed     Abstract available


  74. ANTONINI A, Barone P, Bonuccelli U, Annoni K, et al
    ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017;88:317-324.
    PubMed     Abstract available


  75. FIRBANK MJ, Yarnall AJ, Lawson RA, Duncan GW, et al
    Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    J Neurol Neurosurg Psychiatry. 2017;88:310-316.
    PubMed     Abstract available


    March 2017
  76. LAWSON RA, Yarnall AJ, Duncan GW, Breen DP, et al
    Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-315099.
    PubMed     Abstract available


  77. HO AL, Ali R, Connolly ID, Henderson JM, et al
    Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-314500.
    PubMed     Abstract available


  78. NOYCE AJ, Schrag A, Masters JM, Bestwick JP, et al
    Subtle motor disturbances in PREDICT-PD participants.
    J Neurol Neurosurg Psychiatry. 2017;88:212-217.
    PubMed     Abstract available


    December 2016
  79. TEKRIWAL A, Kern DS, Tsai J, Ince NF, et al
    REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Dec 13. pii: jnnp-2016-314471.
    PubMed     Abstract available


    November 2016
  80. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    PubMed     Abstract available


  81. COLLETT J, Franssen M, Meaney A, Wade D, et al
    Phase II randomised controlled trial of a 6-month self-managed community exercise programme for people with Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Nov 11. pii: jnnp-2016-314508.
    PubMed     Abstract available


    October 2016
  82. DE PABLO-FERNANDEZ E, Breen DP, Bouloux PM, Barker RA, et al
    Neuroendocrine abnormalities in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Oct 31. pii: jnnp-2016-314601.
    PubMed     Abstract available


    September 2016
  83. SWALLOW DM, Lawton MA, Grosset KA, Malek N, et al
    Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313642.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: